Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck
Phase 1
- Conditions
- First Posted Date
- 2004-08-02
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- Hope Cancer Institute, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00003182
- Locations
- ๐บ๐ธ
Bethany Medical Center, Kansas City, Kansas, United States
๐บ๐ธHeartland Cancer Research Network, Kansas City, Kansas, United States
Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Phase 2
- Conditions
- First Posted Date
- 2004-05-21
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- Hope Cancer Institute, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT00003562
- Locations
- ๐บ๐ธ
Heartland Cancer Research Network, Kansas City, Kansas, United States
๐บ๐ธBethany Medical Center, Kansas City, Kansas, United States
Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer
Phase 1
- Conditions
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- Hope Cancer Institute, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT00003183
- Locations
- ๐บ๐ธ
Heartland Cancer Research and Treatment Center, Kansas City, Kansas, United States
๐บ๐ธBethany Medical Center, Kansas City, Kansas, United States
Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer
Phase 2
- Conditions
- First Posted Date
- 2004-04-30
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- Hope Cancer Institute, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT00003181
- Locations
- ๐บ๐ธ
Bethany Medical Center, Kansas City, Kansas, United States
๐บ๐ธHeartland Cancer Research and Treatment Center, Kansas City, Kansas, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath